In vivo hyperspectral imaging of skin malignant and benign tumors in visible spectrum
Paper #3252 received 10 Sep 2017; revised manuscript received 2 Oct 2017; accepted for publication 4 Oct 2017; published online 16 Jan 2018.
DOI: 10.18287/JBPE17.04.010301
Abstract
The paper presents analysis of hyperspectral images for human skin cancer pathologies diagnostics. Hyperspectral images data contained backscattered spectra of normal skin and tumors. Analysis of hyperspectral images provided information about hemoglobin and melanin content for the differentiation of malignant and benign skin neoplasms based on tissues optical density calculation. It was shown that the accuracy of cancerous tissues classification reaches 88% for proposed algorithm of hyperspectral images analysis. The proposed approach may be a rapid and reliable tool for skin oncological diseases screening.
Keywords
Full Text:
PDFReferences
1. All Cancers (excluding non-melanoma skin cancer). Estimated Incidence, Mortality and Prevalence Worldwide in 2012, GLOBOCAN.
2. D. V. Karpin, V. V. Starinskiy, G. V. Petrova (Eds.), The state of oncological care for the population in 2015 in Russia, MORI - P. Herzen Moscow Oncology Research Institute, Moscow (2016) [in Russian].
3. A. V. Ermakov, “Early diagnosis and prophylaxis for cutaneous melanoma,” Oncosurgery 5(3), 52-58 (2013) [in Russian].
4. N. R. Abbasi, H. M. Shaw, D. S. Rigel, R. J. Friedman, W. H. McCarthy, I. Osman, A. W. Kopf, and D. Polsky, “Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria,” JAMA 292(22), 2771–2776 (2004). Crossref
5. F. M. Walter, A. T. Prevost, J. Vasconcelos, P. N. Hall, N. P. Burrows, H. C. Morris, A. L. Kinmonth, and J. D. Emery, “Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study,” British Journal of General Practice 63(610), 345–353 (2013). Crossref
6. G. Argenziano, G. Fabbrocini, P. Carli, V. De Giorgi, E. Sammarco, and M. Delfino, “Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions,” Archives of Dermatology 1341(12), 1563–1570 (1998). Crossref
7. C. Benvenuto-Andrade, S. W. Dusza, A. L. C. Agero, A. Scope, M. Rajadhyaksha, A. C. Halpern, and A. A. Marghoob, “Differences Between Polarized Light Dermoscopy and Immersion Contact Dermoscopy for the Evaluation of Skin Lesions,” Archives of Dermatology 143(3), 329-338 (2007). Crossref
8. P. Bourne, C. Rosendahl, J. Keir, and A. Cameron, “BLINCK—A diagnostic algorithm for skin cancer diagnosis combining clinical features with dermatoscopy findings,” Dermatology Practical & Conceptual 2(2), 55-61 (2012). Crossref
9. C. Rosendahl, G. Williams, D. Eley, T. Wilson, G. Canning, J. Keir, I. McColl, and D. Wilkinson, “The impact of subspecialization and dermatoscopy use on accuracy of melanoma diagnosis among primary care doctors in Australia,” Journal of the American Academy of Dermatology 67(5), 846-852 (2012). Crossref
10. C. Massone, A. Di Stefani, H. P. Soyer, “Dermoscopy for skin cancer detection,” Current Opinion in Oncology 17, 147–153 (2005). Crossref
11. G. Lu, and B. Fei, “Medical hyperspectral imaging: a review,” Journal of Biomedical Optics 19(1), 010901 (2014). Crossref
12. I. Diebele, I. Kuzmina, A. Lihachev, J. Kapostinsh, A. Derjabo, L. Valeine, and J. Spigulis, “Clinical evaluation of melanomas and common nevi by spectral imaging,” Biomedical Optics Express 3(3), 467-472 (2012). Crossref
13. A. Machihin, and V. Pozhar, “Double-AOTF-based aberration-free spectral imaging endoscopic system for biomedical applications,” Journal of Innovative Optical Health Sciences 8(3), 1541009 (2015). Crossref
14. I. A. Bratchenko, M. V. Alonova, O. O. Myakinin, A. A. Moryatov, S. V. Kozlov, and V. P. Zakharov, “Hyperspectral visualization of skin pathologies in visible region,” Computer Optics 40(2), 240-248 (2016). Crossref
15. L. A. Zherdeva, I. A. Bratchenko, O. O. Myakinin, A. A. Moryatov, S. V. Kozlov, and V. P. Zakharov, “In vivo hyperspectral imaging and differentiation of skin cancer,” Proceedings of SPIE 10024, 100244G (2016). Crossref
16. R. O. Duda, P. E. Hart, and D. G. Stork, Pattern Classification, 2nd ed., Wiley (2001).
17. A. N. Bashkatov, E. A. Genina, V. I. Kochubey, and V. V. Tuchin, “Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm,” Journal of Physics D: Applied Physics 38(15), 2543-2555 (2005). Crossref
18. R. L. van Veen, H. J. Sterenborg, A. Pifferi, A. Torricelli, E. Chikoidze, and R. Cubeddu, “Determination of visible near-IR absorption coefficients of mammalian fat using time- and spatially resolved diffuse reflectance and transmission spectroscopy,” Journal of Biomedical Optics 10(5), 054004 (2005). Crossref
19. G. Zonios, J. Bykowski, and N. Kollias, “Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy,” Journal of Investigative Dermatology 117(6), 1452-1457 (2001). Crossref
20. V. P. Zakharov, I. A. Bratchenko, S. V. Kozlov, A. A. Moryatov, O. O. Myakinin, and D. N. Artemyev, “Two-step Raman spectroscopy method for tumor diagnosis,” Proceedings of SPIE 9129, 91293V (2014). Crossref
21. I. A. Bratchenko, D. N. Artemyev, O. O. Myakinin, Y. A. Khristoforova, A. A. Moryatov, S.V. Kozlov, and V. P. Zakharov, “Combined Raman and autofluorescence ex vivo diagnostics of skin cancer in near-infrared and visible regions,” Journal of Biomedical Optics 22(2), 027005 (2017). Crossref
22. E. G. Borisova, L. P. Angelova, and E. P. Pavlova, “Endogenous and Exogenous Fluorescence Skin Cancer Diagnostics for Clinical Applications,” IEEE Journal of Selected Topics in Quantum Electronics 20(2), 211-222 (2014). Crossref
23. J. Zhao, H. Lui, S. Kalia, and H. Zeng, “Real-time Raman spectroscopy for automatic in vivo skin cancer detection: an independent validation,” Analytical and Bioanalytical Chemistry 407(27), 8373–8379 (2015). Crossref
24. S.-H. Tseng, P. Bargo, A. Durkin, and N. Kollias, “Chromophore concentrations, absorption and scattering properties of human skin in-vivo,” Optics Express 17(17), 14599–14617 (2009). Crossref
25. D.T. Dicker, J. Lerner, P. Van Belle, S.F. Barth, D. Guerry 4th, M. Herlyn, D.E. Elder, and W.S. El-Deiry, “Differentiation of normal skin and melanoma using high resolution hyperspectral imaging,” Cancer Biology & Therapy 5(8), 1033-1038 (2006). Crossref
26. Z. Huang, H. Lui, D. I. McLean, M. Korbelik, and H. Zeng, “Raman Spectroscopy in Combination with Back-ground Near-infrared Autofluorescence Enhances the In Vivo Assessment of Malignant Tissues,” Photochemistry and Photobiology 81(5), 1219-1226 (2005). Crossref
27. W. Wang, J. Zhao, M. Short, and H. Zeng, “Real-time in vivo cancer diagnosis using raman spectroscopy,” Journal of Biophotonics 8(7), 527–545 (2014). Crossref
28. X. Feng, A. J. Moy, H. T. M. Nguyen, J. Zhang, M. C. Fox, K. R. Sebastian, J. S. Reichenberg, M. K. Markey, and J. W. Tunnell, “Raman active components of skin cancer,” Biomedical Optics Express 8(6), 2835–2850 (2017). Crossref
29. L. A. Austin, S. Osseiran, and C. L. Evans, “Raman technologies in cancer diagnostics,” Analyst 141(2), 476-503 (2016). Crossref
30. V. P. Zakharov, I. A. Bratchenko, D. N. Artemyev, O. O. Myakinin, D. V. Kornilin, S. V. Kozlov, and A. A. Moryatov, “Comparative analysis of combined spectral and optical tomography methods for detection of skin and lung cancers,” Journal of Biomedical Optics 20(2), 025003 (2015). Crossref
© 2014-2025 Authors
Public Media Certificate (RUS). 12+